,Date,News Headline,Article Link,Source
0,2022-01-10 07:30,InflaRx Announces New Pipeline Program  Oral C5aR Inhibitor,https://finance.yahoo.com/news/inflarx-announces-pipeline-program-oral-123000334.html,GlobeNewswire
1,2022-01-05 08:00,InflaRx Announces Presentation at J.P. Morgan Healthcare Conference and Other Investor Events,https://finance.yahoo.com/news/inflarx-announces-presentation-j-p-130000470.html,GlobeNewswire
2,2021-11-15 15:39,InflaRx's Vilobelimab Shows Encouraging Action Against Rare Autoimmune Disorder,https://finance.yahoo.com/news/inflarxs-vilobelimab-shows-encouraging-action-203922159.html,Benzinga
3,2021-11-15 07:30,InflaRx Announces Positive Data from Phase II IXCHANGE Study with Vilobelimab in ANCA-associated Vasculitis (AAV),https://finance.yahoo.com/news/inflarx-announces-positive-data-phase-123000367.html,GlobeNewswire
4,2021-11-11 07:30,InflaRx to Present at H.C. Wainwright 7th Annual Israel Conference,https://finance.yahoo.com/news/inflarx-present-h-c-wainwright-123000825.html,GlobeNewswire
5,2021-11-08 06:17,Calculating The Fair Value Of InflaRx N.V. (NASDAQ:IFRX),https://finance.yahoo.com/news/calculating-fair-value-inflarx-n-111743994.html,Simply Wall St.
6,2021-11-05 07:30,InflaRx Reports Third Quarter 2021 Financial & Operating Results,https://finance.yahoo.com/news/inflarx-reports-third-quarter-2021-113000807.html,GlobeNewswire
7,2021-11-03 07:30,InflaRx to Present at the Credit Suisse 30th Annual Healthcare Conference,https://finance.yahoo.com/news/inflarx-present-credit-suisse-30th-113000109.html,GlobeNewswire
8,2021-10-28 09:51,Why InflaRx Shares Are Ripping Higher Thursday,https://finance.yahoo.com/news/why-inflarx-shares-ripping-higher-135148611.html,Benzinga
9,2021-10-28 09:49,InflaRx stock rockets on heavy volume after positive trial data on PG treatment prompts analyst upgrade,https://www.marketwatch.com/story/inflarx-stock-rockets-on-heavy-volume-after-positive-trial-data-on-pg-treatment-prompts-analyst-upgrade-2021-10-28?siteid=yhoof2,MarketWatch
10,2021-10-28 07:10,30 Stocks Moving in Thursday's Pre-Market Session,https://finance.yahoo.com/news/30-stocks-moving-thursdays-pre-111030939.html,Benzinga
11,2021-10-28 07:03,InflaRx Stock Upgraded after Positive Data from Phase 2 Study,https://finance.yahoo.com/news/inflarx-stock-upgraded-positive-data-110328472.html,Investing.com
12,2021-10-27 07:30,InflaRx Announces Positive Data from Third Cohort of Phase IIa Open-Label Study with Vilobelimab in Pyoderma Gangraenosum,https://finance.yahoo.com/news/inflarx-announces-positive-data-third-113000114.html,GlobeNewswire
13,2021-10-19 10:08,Mid-Morning Market Update: Markets Open Higher; Johnson & Johnson Boosts FY21 Guidance,https://finance.yahoo.com/news/mid-morning-market-markets-open-140855090.html,Benzinga
14,2021-10-19 07:30,InflaRx Awarded up to EUR 43.7 Million (~USD 50.7 Million) Grant by German Government to Advance the Development of Vilobelimab for Treatment of Severe COVID-19,https://finance.yahoo.com/news/inflarx-awarded-eur-43-7-113000815.html,GlobeNewswire
15,2021-10-12 07:30,InflaRx Completes Enrollment of Vilobelimab Phase III Study in Severe COVID-19,https://finance.yahoo.com/news/inflarx-completes-enrollment-vilobelimab-phase-113000343.html,GlobeNewswire
16,2021-09-09 07:30,InflaRx to Present at the H.C. Wainwright 23rd Annual Global Investment Conference,https://finance.yahoo.com/news/inflarx-present-h-c-wainwright-113000493.html,GlobeNewswire
17,2021-09-08 07:30,InflaRx to Proceed with Pivotal Development for Vilobelimab in Hidradenitis Suppurativa with New Primary Endpoint,https://finance.yahoo.com/news/inflarx-proceed-pivotal-development-vilobelimab-113000064.html,GlobeNewswire
18,2021-08-10 09:17,InflaRx's Vilobelimab Shows Encouraging Signs Of Drug Activity In Mid-Stage Study With Dermatological Ulcer Patients,https://finance.yahoo.com/news/inflarxs-vilobelimab-shows-encouraging-signs-131708325.html,Benzinga
19,2021-08-10 07:30,InflaRx Announces Positive Data from Second Interim Analysis of Ongoing Phase IIa Open Label Study with Vilobelimab in Pyoderma Gangraenosum,https://finance.yahoo.com/news/inflarx-announces-positive-data-second-113000599.html,GlobeNewswire
20,2021-08-06 07:30,InflaRx to Present at the BTIG Virtual Biotechnology Conference,https://finance.yahoo.com/news/inflarx-present-btig-virtual-biotechnology-113000593.html,GlobeNewswire
21,2021-08-05 07:30,InflaRx Reports Second Quarter 2021 Financial & Operating Results,https://finance.yahoo.com/news/inflarx-reports-second-quarter-2021-113000559.html,GlobeNewswire
22,2021-07-28 15:45,Were Hedge Funds Right About InflaRx N.V. (IFRX)?,https://finance.yahoo.com/news/were-hedge-funds-inflarx-n-194521080.html,Insider Monkey
23,2021-06-17 07:30,InflaRx to Present at the Raymond James Human Health Innovation Conference,https://finance.yahoo.com/news/inflarx-present-raymond-james-human-113000018.html,GlobeNewswire
24,2021-06-08 07:30,InflaRx Doses First Patient in Multicenter Phase II Clinical Trial in Cutaneous Squamous Cell Carcinoma with Vilobelimab,https://finance.yahoo.com/news/inflarx-doses-first-patient-multicenter-113000709.html,GlobeNewswire
25,2021-05-30 05:22,We're Hopeful That InflaRx (NASDAQ:IFRX) Will Use Its Cash Wisely,https://finance.yahoo.com/news/were-hopeful-inflarx-nasdaq-ifrx-092230418.html,Simply Wall St.
26,2021-05-21 07:30,Tony Gibney Joins InflaRx Board of Directors,https://finance.yahoo.com/news/tony-gibney-joins-inflarx-board-113000982.html,GlobeNewswire
27,2021-05-12 07:30,InflaRx Reports First Quarter 2021 Financial & Operating Results,https://finance.yahoo.com/news/inflarx-reports-first-quarter-2021-113000998.html,GlobeNewswire
28,2021-05-12 07:15,InflaRx's Vilobelimab Hits Primary Endpoint Goal In Late-Stage ANCA-Associated Vasculitis Study,https://finance.yahoo.com/news/inflarxs-vilobelimab-hits-primary-endpoint-111553827.html,Benzinga
29,2021-05-11 16:30,InflaRx Announces Positive Topline Results for Vilobelimab from the U.S. Phase II ANCA-Associated Vasculitis IXPLORE Study,https://finance.yahoo.com/news/inflarx-announces-positive-topline-results-203000815.html,GlobeNewswire
30,2021-04-15 07:30,InflaRx Completes Enrollment of Vilobelimab Phase IIa Study in Pyoderma Gangraenosum,https://finance.yahoo.com/news/inflarx-completes-enrollment-vilobelimab-phase-113000748.html,GlobeNewswire
31,2021-03-25 06:30,InflaRx Reports Full Year 2020 Financial & Operating Results,https://finance.yahoo.com/news/inflarx-reports-full-2020-financial-103000940.html,GlobeNewswire
32,2021-03-03 07:30,InflaRx to Present at Upcoming Investor Conferences,https://finance.yahoo.com/news/inflarx-present-upcoming-investor-conferences-123000003.html,GlobeNewswire
33,2021-03-01 16:01,InflaRx Announces Closing of $75 Million Public Offering of Common Shares and One-Year Warrants,https://finance.yahoo.com/news/inflarx-announces-closing-75-million-210100964.html,GlobeNewswire
34,2021-03-01 01:54,What Kind Of Investors Own Most Of InflaRx N.V. (NASDAQ:IFRX)?,https://finance.yahoo.com/news/kind-investors-own-most-inflarx-065405368.html,Simply Wall St.
35,2021-02-25 08:30,InflaRx Announces Pricing of $75 Million Public Offering of Common Shares and One-Year Warrants,https://finance.yahoo.com/news/inflarx-announces-pricing-75-million-133000613.html,GlobeNewswire
36,2021-02-24 16:01,InflaRx Announces Proposed Offering of Common Shares and One-Year Warrants,https://finance.yahoo.com/news/inflarx-announces-proposed-offering-common-210100203.html,GlobeNewswire
37,2021-02-11 09:11,InflaRx's Vilobelimab Suppresses Inflammation In Mid-Stage Chronic Skin Disorder Study,https://finance.yahoo.com/news/inflarxs-vilobelimab-suppresses-inflammation-mid-141117189.html,Benzinga
38,2021-02-11 07:30,InflaRx Announces Presentation of New C5a and Vilobelimab (IFX-1) Data from Phase IIB SHINE Study at the 2021 Virtual European Hidradenitis Suppurativa Foundation Conference,https://finance.yahoo.com/news/inflarx-announces-presentation-c5a-vilobelimab-123000995.html,GlobeNewswire
39,2021-01-11 07:30,InflaRx Provides Update on Vilobelimab (IFX-1) Development,https://finance.yahoo.com/news/inflarx-provides-vilobelimab-ifx-1-123000224.html,GlobeNewswire
40,2021-01-07 07:30,InflaRx to Present at Upcoming Annual J.P. Morgan Healthcare Conference,https://finance.yahoo.com/news/inflarx-present-upcoming-annual-j-123000810.html,GlobeNewswire
41,2021-01-05 07:30,InflaRx Completes Enrollment in Vilobelimab (IFX-1) European Phase II Study in ANCA-associated Vasculitis,https://finance.yahoo.com/news/inflarx-completes-enrollment-vilobelimab-ifx-123000709.html,GlobeNewswire
42,2020-12-08 11:35,"These 2 Penny Stocks Could Surge Over 200%, Says Raymond James",https://finance.yahoo.com/news/2-penny-stocks-could-surge-163517880.html,TipRanks
43,2020-12-02 20:30,Hedge Funds Are Dumping InflaRx N.V. (IFRX),https://finance.yahoo.com/news/hedge-funds-dumping-inflarx-n-013008428.html,Insider Monkey
44,2020-11-12 07:02,Will InflaRx (NASDAQ:IFRX) Spend Its Cash Wisely?,https://finance.yahoo.com/news/inflarx-nasdaq-ifrx-spend-cash-120212495.html,Simply Wall St.
45,2020-10-29 07:00,InflaRx Reports Q3 2020 Financial & Operating Results,https://finance.yahoo.com/news/inflarx-reports-q3-2020-financial-110000896.html,GlobeNewswire
46,2020-09-30 04:22,InflaRx Pops 6% On Promising Data From Covid-19 Therapeutic Trial,https://finance.yahoo.com/news/inflarx-pops-6-promising-data-082207885.html,SmarterAnalyst
47,2020-09-17 07:30,InflaRx Announces Leadership Team Additions with New CFO and Newly Created Position of Chief Strategy Officer,https://finance.yahoo.com/news/inflarx-announces-leadership-team-additions-113000995.html,GlobeNewswire
48,2020-09-14 07:30,InflaRx Announces Initiation of Phase III Part of Phase II/III Clinical Trial with IFX-1 in Severe COVID-19 Induced Pneumonia,https://finance.yahoo.com/news/inflarx-announces-initiation-phase-iii-113000453.html,GlobeNewswire
49,2020-08-06 07:30,InflaRx to Present at Upcoming Virtual Investor Events,https://finance.yahoo.com/news/inflarx-present-upcoming-virtual-investor-113000913.html,GlobeNewswire
50,2020-07-30 07:30,InflaRx Reports Q2 2020 Financial & Operating Results,https://finance.yahoo.com/news/inflarx-reports-q2-2020-financial-113000928.html,GlobeNewswire
51,2020-07-24 08:55,Are Options Traders Betting on a Big Move in InflaRx (IFRX) Stock?,https://finance.yahoo.com/news/options-traders-betting-big-move-125512391.html,Zacks
52,2020-07-21 07:30,InflaRx Announces Decision to Enter Phase III Development of IFX-1 in Severe COVID-19 Induced Pneumonia,https://finance.yahoo.com/news/inflarx-announces-decision-enter-phase-113010359.html,GlobeNewswire
53,2020-07-16 11:48,What Kind Of Shareholders Hold The Majority In InflaRx N.V.'s (NASDAQ:IFRX) Shares?,https://finance.yahoo.com/news/kind-shareholders-hold-majority-inflarx-154834392.html,Simply Wall St.
54,2020-07-09 07:33,InflaRx Sees Hammer Chart Pattern: Time to Buy?,https://finance.yahoo.com/news/inflarx-sees-hammer-chart-pattern-113311105.html,Zacks
55,2020-06-25 16:05,Hedge Funds Are Buying InflaRx N.V. (IFRX),https://finance.yahoo.com/news/hedge-funds-buying-inflarx-n-200508389.html,Insider Monkey
56,2020-06-17 07:30,InflaRx Reports Encouraging Topline Results from the Exploratory Phase II Part of the Adaptive Randomized Phase II/III Trial of IFX-1 in COVID-19,https://finance.yahoo.com/news/inflarx-reports-encouraging-topline-results-113010608.html,GlobeNewswire
57,2020-06-11 08:30,"InflaRx (IFRX): Strong Industry, Solid Earnings Estimate Revisions",https://finance.yahoo.com/news/inflarx-ifrx-strong-industry-solid-123012936.html,Zacks
58,2020-05-29 11:10,"The Zacks Analyst Blog Highlights: Bayer Aktiengesellschaft, InflaRx, Legrand, Innate Pharma and DiaSorin",https://finance.yahoo.com/news/zacks-analyst-blog-highlights-bayer-151003198.html,Zacks
59,2020-05-28 08:31,Europe Equities Are Hot on Stimulus Optimism: 5 Picks,https://finance.yahoo.com/news/europe-equities-hot-stimulus-optimism-123112452.html,Zacks
60,2020-05-21 07:30,InflaRx Reports Q1 2020 Financial & Operating Results,https://finance.yahoo.com/news/inflarx-reports-q1-2020-financial-113010708.html,GlobeNewswire
61,2020-04-29 08:00,InflaRx Reports Full Year 2019 Financial & Operating Results,https://finance.yahoo.com/news/inflarx-reports-full-2019-financial-120010122.html,GlobeNewswire
62,2020-04-14 07:30,We're Hopeful That InflaRx (NASDAQ:IFRX) Will Use Its Cash Wisely,https://finance.yahoo.com/news/were-hopeful-inflarx-nasdaq-ifrx-113011356.html,Simply Wall St.
63,2020-04-01 16:18,Covid Report: Testing News Sends One Biotech Flying As Another Dives,https://www.investors.com/news/technology/coronavirus-treatment-biotech-companies-gilead-inflarx-diverge/?src=A00220,Investor's Business Daily
64,2020-04-01 07:38,"The Daily Biotech Pulse: InflaRx Begins Human Testing For COVID-induced Pneumonia, Chembio, Becton Dickinson Launch Coronavirus Tests",https://finance.yahoo.com/news/daily-biotech-pulse-inflarx-begins-113815888.html,Benzinga
65,2020-03-31 16:15,InflaRx Doses First Patient in Multicenter Randomized Clinical Trial in Severe Progressed COVID-19 Pneumonia in Europe upon Receipt of Initial Positive Human Data with InflaRxs anti-C5a Technology,https://finance.yahoo.com/news/inflarx-doses-first-patient-multicenter-201510473.html,GlobeNewswire
66,2020-03-06 10:49,"4 Smaller, Cash-Rich Biotech Stocks That Could Be Havens",https://www.barrons.com/articles/4-smaller-cash-rich-biotech-stocks-that-could-be-safe-havens-51583509703?siteid=yhoof2,Barrons.com
67,2020-02-26 07:30,InflaRx Announces Positive Initial Data from Ongoing Phase IIa Open Label Study with IFX-1 in Patients Suffering from Pyoderma Gangraenosum,https://finance.yahoo.com/news/inflarx-announces-positive-initial-data-123010568.html,GlobeNewswire
68,2020-02-19 08:00,InflaRx to Present at Upcoming SVB Leerink Global Healthcare Conference,https://finance.yahoo.com/news/inflarx-present-upcoming-svb-leerink-130010948.html,GlobeNewswire
69,2020-01-09 07:30,InflaRx to Present at Upcoming J.P. Morgan Annual Healthcare Conference,https://finance.yahoo.com/news/inflarx-present-upcoming-j-p-123010695.html,GlobeNewswire
70,2019-12-20 19:45,Did Hedge Funds Drop The Ball On InflaRx N.V. (IFRX) ?,https://finance.yahoo.com/news/did-hedge-funds-drop-ball-004529188.html,Insider Monkey
71,2019-11-07 07:30,InflaRx Reports Third Quarter 2019 Financial & Operating Results,https://finance.yahoo.com/news/inflarx-reports-third-quarter-2019-123000446.html,ACCESSWIRE
72,2019-11-07 07:18,"The Daily Biotech Pulse: Obseva Sinks On Adverse Clinical Readout, BioNano Surges On Saphyr Adoption, 2 IPOs",https://finance.yahoo.com/news/daily-biotech-pulse-obseva-sinks-121813657.html,Benzinga
73,2019-11-07 02:10,InflaRx Reports Positive Results from the Open Label Extension Part of the SHINE Study for IFX-1 in Hidradenitis Suppurativa,https://finance.yahoo.com/news/inflarx-reports-positive-results-open-071000698.html,ACCESSWIRE
74,2019-10-17 08:43,Here's Why We're Watching InflaRx's (NASDAQ:IFRX) Cash Burn Situation,https://finance.yahoo.com/news/heres-why-were-watching-inflarxs-124300224.html,Simply Wall St.
75,2019-08-14 16:05,InflaRx Reports Second Quarter 2019 Financial & Operating Results,https://finance.yahoo.com/news/inflarx-reports-second-quarter-2019-200500620.html,GlobeNewswire
76,2019-07-19 12:43,Do Insiders Own Shares In InflaRx N.V. (NASDAQ:IFRX)?,https://finance.yahoo.com/news/insiders-own-shares-inflarx-n-164326048.html,Simply Wall St.
77,2019-07-18 16:01,InflaRx Reports Additional Analysis of the SHINE Phase IIb Results for IFX-1 in Hidradenitis Suppurativa,https://finance.yahoo.com/news/inflarx-reports-additional-analysis-shine-200100545.html,GlobeNewswire
78,2019-07-18 09:55,InflaRx Enters Oversold Territory,https://finance.yahoo.com/news/inflarx-enters-oversold-territory-135501449.html,Zacks
79,2019-06-29 23:31,Hedge Funds Have Never Been This Bullish On InflaRx N.V. (IFRX),https://finance.yahoo.com/news/hedge-funds-never-bullish-inflarx-033153032.html,Insider Monkey
80,2019-06-13 10:18,InflaRx Enters Oversold Territory,https://finance.yahoo.com/news/inflarx-enters-oversold-territory-141802378.html,Zacks
81,2019-06-13 09:00,InflaRx Treats First Patient in Phase IIa Clinical Trial with Lead Candidate IFX-1 in Pyoderma Gangraenosum,https://finance.yahoo.com/news/inflarx-treats-first-patient-phase-130000215.html,GlobeNewswire
82,2019-06-05 16:18,InflaRx shares plummet over 90% after drug test failure,https://finance.yahoo.com/video/inflarx-shares-plummet-over-90-201845444.html,Yahoo Finance Video
83,2019-06-05 07:49,InflaRx Announces Top-Line SHINE Phase IIb Results for IFX-1 in Hidradenitis Suppurativa,https://finance.yahoo.com/news/inflarx-announces-top-line-shine-114923943.html,GlobeNewswire
84,2019-05-23 09:15,"InflaRx N.V. (IFRX) Reports Q1 Loss, Lags Revenue Estimates",https://finance.yahoo.com/news/inflarx-n-v-ifrx-reports-131501818.html,Zacks
85,2019-05-23 08:00,InflaRx Reports First Quarter 2019 Financial & Operating Results,https://finance.yahoo.com/news/inflarx-reports-first-quarter-2019-120000012.html,GlobeNewswire
86,2019-05-14 08:00,InflaRx Commences Second Phase II Clinical Trial of IFX-1 in ANCA-Associated Vasculitis with First Patient Treated in Europe,https://finance.yahoo.com/news/inflarx-commences-second-phase-ii-120000879.html,GlobeNewswire
87,2019-05-03 10:12,Did Hedge Funds Drop The Ball On InflaRx N.V. (IFRX)?,https://finance.yahoo.com/news/did-hedge-funds-drop-ball-141221179.html,Insider Monkey
88,2019-04-10 08:45,InflaRx (IFRX) Catches Eye: Stock Jumps 7.5%,https://finance.yahoo.com/news/inflarx-ifrx-catches-eye-stock-124512470.html,Zacks
89,2019-03-28 08:30,InflaRx Full Year 2018 Financial & Operating Results,https://finance.yahoo.com/news/inflarx-full-2018-financial-operating-123000370.html,GlobeNewswire
90,2019-03-12 07:37,InflaRx (NASDAQ:IFRX) Shareholders Booked A 63% Gain In The Last Year,https://finance.yahoo.com/news/inflarx-nasdaq-ifrx-shareholders-booked-113723383.html,Simply Wall St.
91,2019-02-27 08:30,InflaRx Receives Approval to Initiate Phase IIa Clinical Trial with Lead Candidate IFX-1 in Pyoderma Gangraenosum,https://finance.yahoo.com/news/inflarx-receives-approval-initiate-phase-133000329.html,GlobeNewswire
92,2019-02-25 07:30,"Market Trends Toward New Normal in Nuance Communications, Fate Therapeutics, Hamilton Lane, InflaRx N.V, Enerplus, and ManTech International  Emerging Consolidated Expectations, Analyst Ratings",https://finance.yahoo.com/news/market-trends-toward-normal-nuance-123000478.html,GlobeNewswire
93,2019-02-14 08:30,Richard Brudnick to Join InflaRx Board of Directors,https://finance.yahoo.com/news/richard-brudnick-join-inflarx-board-133000915.html,GlobeNewswire
94,2019-02-06 07:00,InflaRx Announces Presentation of New Clinical Data with Lead Candidate IFX-1 in Hidradenitis Suppurativa,https://finance.yahoo.com/news/inflarx-announces-presentation-clinical-data-120000758.html,GlobeNewswire
95,2019-01-03 08:30,InflaRx Continues U.S. Expansion with Addition of New York City Corporate Office and Addition of Management,https://finance.yahoo.com/news/inflarx-continues-u-expansion-addition-133000541.html,GlobeNewswire
96,2018-12-22 03:43,Is InflaRx N.V. (IFRX) A Good Stock To Buy?,https://finance.yahoo.com/news/inflarx-n-v-ifrx-good-084302879.html,Insider Monkey
97,2018-12-19 08:30,InflaRx Receives European Approval to Initiate Phase II Clinical Trial with IFX-1 in ANCA-Associated Vasculitis,https://finance.yahoo.com/news/inflarx-receives-european-approval-initiate-133000733.html,GlobeNewswire
98,2018-11-21 08:30,InflaRx N.V. Reports Third Quarter 2018 Financial & Operating Results,https://finance.yahoo.com/news/inflarx-n-v-reports-third-133000150.html,GlobeNewswire
99,2018-11-08 02:30,InflaRx Completes Enrollment in Phase IIb Clinical Trial with Lead Candidate IFX-1 in Hidradenitis Suppurativa,https://finance.yahoo.com/news/inflarx-completes-enrollment-phase-iib-073000018.html,GlobeNewswire
